MetLife Investment Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $271K | Buy |
|
|||||
|
2025
Q1 | $135K | Sell |
|
|||||
|
2024
Q4 | $229K | Hold |
|
|||||
|
2024
Q3 | $256K | Hold |
|
|||||
|
2024
Q2 | $281K | Buy |
|
|||||
|
2024
Q1 | $112K | Sell |
|
|||||
|
2023
Q4 | $76.9K | Hold |
|
|||||
|
2023
Q3 | $57.6K | Hold |
|
|||||
|
2023
Q2 | $155K | Buy |
|
|||||
|
2023
Q1 | $96.8K | Hold |
|
|||||
|
2022
Q4 | $107K | Hold |
|
|||||
|
2022
Q3 | $149K | Hold |
|
|||||
|
2022
Q2 | $154K | Hold |
|
|||||
|
2022
Q1 | $245K | Buy |
|
|||||
|
2021
Q4 | $176K | Hold |
|
|||||
|
2021
Q3 | $187K | Hold |
|
|||||
|
2021
Q2 | $247K | Buy |
|
|||||
|
2021
Q1 | $213K | Hold |
|
|||||
|
2020
Q4 | $339K | Sell |
|
|||||
|
2020
Q3 | $262K | Hold |
|
|||||
|
2020
Q2 | $186K | Hold |
|
|||||
|
2020
Q1 | $179K | Buy |
|
|||||
|
2019
Q4 | $135K | Buy |
|